Knight Therapeutics Inc
(TSX:GUD)
C$
5.43
0.02 (0.37%)
Market Cap: 550.47 Mil
Enterprise Value: 428.31 Mil
PE Ratio: 0
PB Ratio: 0.72
GF Score: 87/100 - Q4 2023 Knight Therapeutics Inc Earnings Call TranscriptMar 21, 2024C$5.23 (-2.97%)Earnings
- Q3 2023 Knight Therapeutics Inc Earnings Call TranscriptNov 09, 2023C$4.99 (+4.39%)Earnings
- Q2 2023 Knight Therapeutics Inc Earnings Call TranscriptAug 10, 2023C$4.84 (+0.21%)Earnings
- Q1 2023 Knight Therapeutics Inc Earnings Call TranscriptMay 11, 2023C$4.81 (+2.12%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q4 2022 Knight Therapeutics Inc Earnings Call TranscriptMar 23, 2023C$4.84 (-1.22%)Earnings
- Q3 2022 Knight Therapeutics Inc Earnings Call TranscriptNov 10, 2022C$5.31 (-1.67%)Earnings
- Q2 2022 Knight Therapeutics Inc Earnings Call TranscriptAug 11, 2022C$5.97 (+7.37%)Earnings
- Q1 2022 Knight Therapeutics Inc Earnings Call TranscriptMay 12, 2022C$5.19 (-0.57%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptMay 11, 2022
- Q4 2021 Knight Therapeutics Inc Earnings Call TranscriptMar 24, 2022C$5.22 (-6.12%)Earnings
- Q3 2021 Knight Therapeutics Inc Earnings Call TranscriptNov 11, 2021C$5.29 (+0.76%)Earnings
- Q2 2021 Knight Therapeutics Inc Earnings Call TranscriptAug 13, 2021C$5.6 (+8.95%)Earnings
- Q1 2021 Knight Therapeutics Inc Earnings Call TranscriptMay 14, 2021C$5.35 (+1.90%)Earnings
- Knight Therapeutics Inc Host A Conference Call To Discuss The Exelon Acquisition TranscriptApr 23, 2021
- Q4 2020 Knight Therapeutics Inc Earnings Call TranscriptMar 25, 2021C$5.23 (+4.81%)Earnings
- Q3 2020 Knight Therapeutics Inc Earnings Call TranscriptNov 13, 2020C$5.39 (-0.37%)Earnings
- Q2 2020 Knight Therapeutics Inc Earnings Call TranscriptAug 13, 2020C$6.75 (+0.45%)Earnings
- Q1 2020 Knight Therapeutics Inc Earnings Call TranscriptJun 26, 2020C$6.82 (-6.19%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q4 2019 Knight Therapeutics Inc Earnings Call TranscriptMar 30, 2020C$6.13 (+2.34%)Earnings
- Q3 2019 Knight Therapeutics Inc Earnings Call TranscriptNov 12, 2019C$8.08 (-1.70%)Earnings
- Knight Therapeutics Inc M&A Call TranscriptOct 21, 2019
- Q2 2019 Knight Therapeutics Inc Earnings Call TranscriptAug 08, 2019C$7.44 (+0.81%)Earnings
- Q1 2019 Knight Therapeutics Inc Earnings Call TranscriptMay 09, 2019C$7.47 (-0.40%)Earnings
- Q4 2018 Knight Therapeutics Inc Earnings Call TranscriptMar 14, 2019C$7.55 (+0.27%)Earnings
Q3 2022 Knight Therapeutics Inc Earnings Call Transcript
Release Date Price:
C$5.31
(-1.67%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)